A Multicenter, Randomized, Double-Blind, 12-Week Study Of The Safety And Efficacy Of AN2728 Versus AN2728 Vehicle In The Treatment Of Patients With Mild-To-Moderate Plaque-Type Psoriasis

Trial Profile

A Multicenter, Randomized, Double-Blind, 12-Week Study Of The Safety And Efficacy Of AN2728 Versus AN2728 Vehicle In The Treatment Of Patients With Mild-To-Moderate Plaque-Type Psoriasis

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Apr 2017

At a glance

  • Drugs Crisaborole (Primary)
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Sponsors Anacor Pharmaceuticals
  • Most Recent Events

    • 28 Jun 2011 Status changed from active, no longer recruiting to completed, according to information in an Anacor Pharmaceuticals media release.
    • 19 Apr 2011 Results will be presented at the 2011 Society for Investigative Dermatology (SID) Annual Meeting, according to a Anacor media release.
    • 15 Mar 2011 Final results are expected in mid-2011, according to an Anacor Pharmaceuticals media release,
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top